Article contents
Transcatheter closure of ventricular septal defect with Occlutech Duct Occluder
Part of:
Interventional Cardiology
Published online by Cambridge University Press: 07 March 2018
Abstract
Patent ductus arteriosus occluders are used for transcatheter closure of ventricular septal defects, as well as for closure of patent ductus arteriosus. The Occlutech Duct Occluder is a newly introduced device for transcatheter closure of patent ductus arteriosus. Here, we present a case in which the Occlutech Duct Occluder was successfully used on a patient for the closure of a perimembraneous ventricular septal defect.
- Type
- Brief Report
- Information
- Copyright
- © Cambridge University Press 2018
References
1.
Yang, L, Tai, BC, Khin, LW, Quek, SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Interv Cardiol
2014; 27: 260–272.Google Scholar
2.
Kudumula, V, Taliotis, D, Duke, C. The new Occlutech Duct Occluder: immediate results, procedural challenges, and short-term follow-up. J Invasive Cardiol
2015; 27: 250–257.Google Scholar
3.
El Said, HG, Bratincsak, A, Gordon, BM, Moore, JW. Closure of perimembranous ventricular septal defects with aneurysmal tissue using the Amplazter Duct Occluder I: lessons learned and medium term follow up. Catheter Cardiovasc Interv
2012; 80: 895–903.CrossRefGoogle ScholarPubMed
4.
Dedeoglu, R, Bilici, M, Demir, F, et al. Short-term outcomes of patent ductus arteriosus closure with new Occlutech® Duct Occluder: a multicenter study. J Interv Cardiol
2016; 29: 325–331.Google Scholar
Video
1.6 MB
Video
1 MB
Video
775.2 KB
- 4
- Cited by